A Quality Compounder Trading at a Recovery Valuation

The market rarely offers high-quality businesses at attractive valuations without giving investors a reason to worry. In Serco’s case, those concerns have centred almost entirely around procurement delays in North America. The shares have fallen nearly 30% since March, underperforming both the wider FTSE 250 and many of its defence-related peers.

That disconnect between sentiment and fundamentals creates an interesting opportunity. While Serco may not be the highest growth company in the market, it continues to demonstrate the characteristics that often underpin attractive long-term shareholder returns.

Executing well despite a mixed backdrop

Serco’s latest trading update was encouraging.

The company expects first-half revenue of around £2.5 billion, representing growth of approximately 3%, while underlying operating profit is expected to increase around 6% to £155 million. Management also reiterated full-year guidance for approximately £5 billion of revenue and around £300 million of underlying operating profit, implying earnings growth of roughly 10% compared with last year.

Importantly, that improvement is not simply being driven by higher revenues.

Continued productivity initiatives, disciplined cost control and a more favourable contract mix are all helping to lift operating margins towards 6%, placing Serco at the upper end of its medium-term profitability target. In an environment where many companies are still battling inflationary cost pressures, improving margins often tell you more about management quality than headline revenue growth.

Performance across the wider business also remains encouraging.

The UK & Europe division continues to benefit from Defence and Justice contract mobilisations alongside stronger-than-expected activity within immigration services. Asia Pacific has secured several sizeable contract extensions, while the Middle East continues to perform resiliently despite the geopolitical backdrop.

Looking beyond the North American headlines

The one obvious weakness remains North America.

Government procurement delays have persisted longer than management originally anticipated, leading some investors to question the near-term outlook. However, I think it is important to separate delays from deterioration.

Management highlighted that its North American pipeline has continued to expand, contributing towards a total group pipeline of £12.5 billion. During the period, Serco secured more than £2 billion of contract awards and extensions, while Asia Pacific generated over £500 million of new order intake.

In other words, customers are still spending. They are simply taking longer to award new work.

That distinction matters because procurement delays can depress short-term earnings expectations without necessarily changing the longer-term earnings potential of the business. Should procurement activity begin to normalise during the second half, investor sentiment could improve quite quickly.

Financial strength remains a competitive advantage

Serco also continues to demonstrate the balance sheet discipline that has become a hallmark of the business.

The current £75 million share buyback programme is due to complete later this month, after which the Board intends to review its capital allocation strategy. For long-term investors, continued cash generation alongside disciplined capital management remains an attractive combination.

Technical outlook

From a technical perspective, the share price appears to be reaching an interesting point.

Since peaking above 320p in March, Serco has undergone a prolonged correction, retracing almost exactly 50% of the rally that developed throughout 2025 and into early 2026. That retracement also coincides with an area that previously acted as resistance during the second half of last year before eventually giving way.

While no technical level guarantees support, these areas often attract renewed institutional interest as investors reassess the underlying fundamentals.

Momentum indicators are also beginning to improve. Having spent several weeks in oversold territory, the Relative Strength Index has started to recover, suggesting downside momentum is beginning to fade. We are not yet looking at a confirmed uptrend, but the recent stabilisation is certainly more encouraging than the persistent selling pressure seen throughout the second quarter.

For investors considering building a position, this represents a much more attractive entry point than chasing the stock after its sharp advance earlier this year.

Growth at a reasonable price

Despite continuing to execute operationally, Serco still trades on a forward earnings multiple of around 12 times.

That looks undemanding for a business expected to deliver double-digit profit growth, improving margins and robust free cash flow. Consensus forecasts point towards earnings per share growth approaching 17% over the coming year, while the average analyst price target remains comfortably above the current share price.

The market is effectively pricing Serco as though North American procurement delays represent a structural problem. Management’s commentary suggests something rather different. Demand remains intact, the pipeline continues to expand and the rest of the business is performing well.

If procurement activity begins to recover as expected, there is scope for both earnings upgrades and a re-rating of the valuation multiple.

Five Key Takeaways

1. Improving profitability: Management continues to expand operating margins through productivity gains and disciplined cost control, supporting around 10% operating profit growth this year.

2. Pipeline continues to grow: Despite procurement delays in North America, Serco’s contract pipeline has expanded to £12.5 billion, reinforcing confidence in longer-term demand.

3. Strong financial position: Low leverage, robust free cash flow and an ongoing £75 million share buyback provide considerable financial flexibility.

4. Technical picture improving: The shares have retraced around 50% of the 2025-26 rally while the RSI has begun recovering from oversold territory, suggesting selling pressure is fading.

5. Valuation looks attractive: Trading on roughly 12x forward earnings despite improving fundamentals, Serco offers an appealing combination of quality, cash generation and recovery potential.